358 related articles for article (PubMed ID: 28189377)
1. Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant Trichophyton rubrum.
de Oliveira Lima MI; Araújo de Medeiros AC; Souza Silva KV; Cardoso GN; de Oliveira Lima E; de Oliveira Pereira F
J Mycol Med; 2017 Jun; 27(2):195-202. PubMed ID: 28189377
[TBL] [Abstract][Full Text] [Related]
2. Inibitory effects of linalool on fungal pathogenicity of clinical isolates of Microsporum canis and Microsporum gypseum.
Silva KVS; Lima MIO; Cardoso GN; Santos AS; Silva GS; Pereira FO
Mycoses; 2017 Jun; 60(6):387-393. PubMed ID: 28198097
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis.
Pereira Fde O; Mendes JM; Lima IO; Mota KS; Oliveira WA; Lima Ede O
Pharm Biol; 2015 Feb; 53(2):228-34. PubMed ID: 25414073
[TBL] [Abstract][Full Text] [Related]
4. Investigation on mechanism of antifungal activity of eugenol against Trichophyton rubrum.
de Oliveira Pereira F; Mendes JM; de Oliveira Lima E
Med Mycol; 2013 Jul; 51(5):507-13. PubMed ID: 23181601
[TBL] [Abstract][Full Text] [Related]
5. Linalool modulates dermatophyte susceptibility to azole drugs.
Ponte HAS; Lima MIO; Lima EO; Pereira FO
Med Mycol; 2020 Feb; 58(2):272-274. PubMed ID: 31329906
[TBL] [Abstract][Full Text] [Related]
6. [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
Solgun G; Fındık D; Türk Dağı H; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):159-67. PubMed ID: 21341170
[TBL] [Abstract][Full Text] [Related]
7. Synergistic combination of violacein and azoles that leads to enhanced killing of major human pathogenic dermatophytic fungi Trichophyton rubrum.
Anju S; Kumar NS; Krishnakumar B; Kumar BS
Front Cell Infect Microbiol; 2015; 5():57. PubMed ID: 26322275
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
9.
Singh SK; Patwa DK; Tilak R; Das A; Singh TB
Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
[TBL] [Abstract][Full Text] [Related]
10. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
da Silva Barros ME; de Assis Santos D; Soares Hamdan J
Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ
Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211
[TBL] [Abstract][Full Text] [Related]
13. [Resistance to azolic compounds in clinical Trichophyton spp. strains].
Méndez-Tovar LJ; Manzano-Gayosso P; Velásquez-Hernández V; Millan-Chiu B; Hernández-Hernández F; Mondragón-González R; López-Martínez R
Rev Iberoam Micol; 2007 Dec; 24(4):320-2. PubMed ID: 18095769
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
15. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
Monti D; Mazzantini D; Tampucci S; Vecchione A; Celandroni F; Burgalassi S; Ghelardi E
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
[TBL] [Abstract][Full Text] [Related]
16. Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
Balci DD; Cetin M
Mycoses; 2008 Nov; 51(6):546-8. PubMed ID: 18422918
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
[TBL] [Abstract][Full Text] [Related]
18. Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.
Hryncewicz-Gwóźdź A; Kalinowska K; Plomer-Niezgoda E; Bielecki J; Jagielski T
Mycopathologia; 2013 Aug; 176(1-2):49-55. PubMed ID: 23595653
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
Goh CL; Tay YK; Ali KB; Koh MT; Seow CS
Int J Dermatol; 1994 Oct; 33(10):733-7. PubMed ID: 8002147
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes.
Santos DA; Hamdan JS
Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
